MedPath

A clnical study to assess inhibitory effect of bepotastine besilate OD tablet to compare with fexofenadine hydrochloride and pseudoephedrine hydrochloride combination tablet in patients with cedar pollinosis in the OHIO Chamber.

Not Applicable
Conditions
Japanese cedar Pollinosis
Registration Number
JPRN-UMIN000010687
Lead Sponsor
Samoncho Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
56
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with mucosal lesion of the nose and eyes. 2)Patients with severe or requiring treatment needed Allergic Rhinitis. 3)Patients who received steroid injections within 6 months. 4)Patients with respiratory disease such as asthma. 5)Patients with past history of anaphylaxis. 6)Patients who have anaphylaxis with these drugs. 7)Patients with pregnancy, delivery or lactation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subjective symptoms
Secondary Outcome Measures
NameTimeMethod
asal secretion volume Number of sneezing Exercise-based treatment programs
© Copyright 2025. All Rights Reserved by MedPath